The company
Imunon, Inc.
IMNN · Nasdaq
IMNN stood above a rising 150-day average in 0 of the last 52 weekly readings. It is 49.8% below that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).
Statistics
- Rotation
- Not moving yet
- Weeks in an uptrend
- out for 52
- Industry in uptrend
- 15% -17 in 4 wk
- Insider buys, 12 months
- $0
- Insider sales, 12 months
- $76K
- Officials’ trades on record
- 0
- Institutions holding
- 22 (+5)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 0 of 52 weeks.
Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
No member of Congress or official has disclosed a trade in it.
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Susan EylwardGeneral Counsel and Corp Sec | sold | 2,525at $1.56 | 31 Aug 2026filed 1 Sep 2026 |
| Susan EylwardGeneral Counsel and Corp Sec | sold | 2,449at $1.63 | 17 Aug 2026filed 17 Aug 2026 |
| Susan EylwardGeneral Counsel and Corp Sec | sold | 2,541at $1.57 | 3 Aug 2026filed 4 Aug 2026 |
| Susan EylwardGeneral Counsel and Corp Sec | sold | 2,150at $1.78 | 20 Jul 2026filed 21 Jul 2026 |
| Susan EylwardGeneral Counsel and Corp Sec | sold | 920at $1.88 | 6 Jul 2026filed 7 Jul 2026 |
| Susan EylwardGeneral Counsel and Corp Sec | sold | 11,800at $1.75 | 29 Jun 2026filed 29 Jun 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| ARMISTICE CAPITAL, LLCreduced · filed 14 Aug 2026 | 144,767$258K | -203,563−58.4% |
| VANGUARD CAPITAL MANAGEMENT LLCreduced · filed 13 Aug 2026 | 46,967$84K | -1,089−2.3% |
| Riverview Capital Advisers, LLCunchanged · filed 13 Aug 2026 | 34,364$248K | 00.0% |
| GEODE CAPITAL MANAGEMENT, LLCreduced · filed 12 Aug 2026 | 31,629$56K | -1,582−4.8% |
| VANGUARD FIDUCIARY TRUST COunchanged · filed 13 Aug 2026 | 13,269$24K | 00.0% |
| NORTHERN TRUST CORPnew · filed 13 Aug 2026 | 10,342$18K | +10,342 |
| UBS Group AGadded · filed 13 Aug 2026 | 5,203$9,261 | +4,628+804.9% |
| BlackRock, Inc.unchanged · filed 7 Aug 2026 | 4,464$7,946 | 00.0% |
| Tower Research Capital LLC (TRC)added · filed 11 Aug 2026 | 3,952$7,035 | +2,086+111.8% |
| WELLS FARGO & COMPANYunchanged · filed 14 Aug 2026 | 3,342$5,948 | 00.0% |
News
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.